Arbutus Biopharma Corp. (ABUS)
Q4 2018 Results Conference Call
March 07, 2019 04:30 PM ET
Company Participants
Pam Murphy - Investor Relations
Mark Murray - CEO
Mike Sofia - Chief Scientific Officer
Gaston Picchio - Chief Development Officer
Dave Hastings - Chief Financial Officer
Conference Call Participants
Katherine Xu - William Blair
Keay Nakae - Chardan
Mayank Mamtani - B Riley
Presentation
Operator
Good day, ladies and gentlemen. And welcome to Arbutus Biopharma Fourth quarter and 2018 Year-End Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a